Our group has previously shown EphA2 hyperphosphorylation in esophageal cancer based on cell line phosphotyrosine profiling data [11], whereas EphA2 and EphB4 have been upregulated in breast cancer [28]. This evidence concerns the gene EPHA2 and breast carcinoma.